Tendler Craig — SEC Form 4 filings
SEC reporting owner CIK 2061924. 3 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.
Transaction summary — filings shown
Covers all 3 filings on record, filed 2025-03-19 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | Director | 2 | — | — | 2 |
| Parabilis Medicines, Inc. (PBLS) | Director | 1 | — | — | 1 |
Form 4 filings — Tendler Craig
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Parabilis Medicines, Inc. (PBLS) | Grant/award (A): 20,294 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | TuHURA Biosciences, Inc./NV (HURA) | Grant/award (A): 156,240 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | TuHURA Biosciences, Inc./NV (HURA) | Grant/award (A): 151,883 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2061924 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →